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Background: Current rodent models for diabetes mellitus type 2 could be divided into genetic-engineered and
environmental-induced. Since genetic-modified rodents are difficult to acquire and costly for Thai researchers,
we tried to develop a protocol for food-induced diabetic rats.
Objectives: To develop a convenient and economical type 2 diabetic mellitus rats with a short course (4 - week)
of induction for research purpose.
Methods: Eight-week-old male Wistar rats were divided into two groups: control group and streptozotocin with
high-fat diet (STZ-HFD) group (n = 4 each). The control group received normal chow (c.p.082 diet with 20.0%
energy from fat). For the STZ-HFD group, STZ (30 mg/kg) was intraperitoneal injected at week 0 of experiment
with HFD feeding (58.0% energy from fat). Rats were fed ad libitum. Blood samples were collected for diabetic
evaluation weekly for 4 weeks.
Results: The body weight of the STZ-HFD group was significantly higher than that of the control group.
Blood glucose, plasma insulin, homeostasis model assessment of insulin resistance (HOMA-IR) index and
HbA1C were increased in the STZ-HFD group. Moreover, STZ-HFD rats suffered with a non-alcoholic fatty liver
disease.
Conclusion: Low dose STZ injection (30 mg/kg) with HFD feeding (58.0% energy from fat) could be used to
induced type 2 diabetes in rats within 4 weeks.
Keywords: Type 2 diabetes, animal model, high-fat diet, streptozotocin.

Diabetes mellitus (DM) is a chronic disease
characterized by elevated blood glucose level due to
abnormal secretion or response of insulin, a hormone
that plays a vital role in regulation of blood glucose
levels. Insulin is synthesized and released by beta
cells of islets of Langerhans in the pancreas. Insulin
facilitates glucose uptake of adipocytes and muscle
cells as well as enhances glucose utilization in several
tissues. Therefore, decreased insulin secretion or
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function leads to hyperglycemia. Furthermore, longterm hyperglycemia causes several complications such
as atherosclerosis, fatty liver, diabetic nephropathy,
and diabetic retinopathy.
Diabetes mellitus is categorized into several types,
however, two major etiologies were identified: insulin
deficiency (such as, type 1 DM, mature-onset diabetes
in the young or MODY) and insulin resistance
(type 2 DM, gestational DM, etc.) In the present
study, we mainly discuss about type 1 and type 2 DM.
Type 1 DM is characterized by insulin deficiency
due to the destruction of beta cell, which is commonly
caused by autoimmune disease, or toxins such as
alcohol and drugs (streptozotocin, etc.) Type 1 DM
is usually diagnosed in childhood period and required
extrinsic insulin injection to maintain normal serum
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glucose. While type 2 DM is the most common type
of DM found in global population, accounted for more
than 90.0% of all diabetic patients. Type 2 DM is
caused by insulin resistance and relative insulin
deficiency. Insulin resistance is a condition that
normal insulin level could not lower serum glucose to
the appropriate level, thus beta cell is stimulated to
secrete higher insulin amount to keep normoglycemia
or slightly hyperglycemia. Type 2 DM is characterized
by hyperinsulinemia with hyperglycemia. This disease
is genetic predisposing with multifactorial risk factors,
such as obesity, aging, and low physical activity. (1)
Although the typical presentations of type 1
and type 2 DM are similar, but their pathogenesis,
complication and treatment are different. For example,
ketoacidosis is more common in type 1 DM, while
hyperinsulinemia in type 2 DM is associated with
obesity, non-alcoholic steatohepatitis, and abnormal
urinary acidification. Regarding this, studies in
pathogenetic and therapeutic aspects of diabetes must
be concerned about this discrepancy. In diabetic
research in Thailand, rodents are commonly used
for a few decades. Type 1 diabetes is conveniently
achieved by drug-induced destruction of beta-cells.
Streptozotocin, an antibiotic that induces beta cells
death, is widely used to induce type 1 diabetes in animal
models. (2) This drug enters the pancreatic beta cell
through glucose transporter 2 (GLUT2) and causes
alkylation of DNA leading to beta cell death. Thus,
insulin production is reduced. (3 - 5)
For type 2 diabetes model, currently geneticallyengineered such as Lepob/ob mice, Leprdb/db mice were
generally used, because these mice were geneticallyinduced severe obesity, subsequently developed
type 2 DM without further procedure is required.
The diabetogenesis of these type 2 diabetic mice due
to the dysfunction of leptin hormone, leading to severe
hyperphagia, morbid obesity and insulin resistance.
However, these mice are not available in Thailand
and the cost is very high (more than 10,000 baht
each or about 10 - 20 times of conventional bred
rodents. (6)) Many Thai researchers preferred to use
external stimulation to induce type 2 diabetes, such as
high fat diet feeding with or without drug induction.
High-fat feeding induces weight gain and fat
accumulation, obesity and insulin resistance, similar
to genetic-modified mice.(7) However, The protocols
were vastly different in age and strain of rodents,
composition of high fat diet and induction time.
In addition, many models preferred to utilize both
drug and diet to induce diabetes, which were also
various in dosage and route of administration.(8) The
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precaution of these models were that the longer
the induction time, the higher rate of degenerative
disease including diabetes itself could be detected in
control animals, and high dose of drug used to cause
partial beta cell destruction associated with high
chance of type 1 DM development in older animals.
According this, the age of rodents, induction time and
dosage of the drug were the main factors contributed
to the accomplishment of the experiment.
Although there were several protocols for type 2
diabetes rodent induction in international reports,(2, 8)
but very limited in Thai studies. This study targeted to
establish a budget and convenient type 2 diabetes
rats using both high-fat diet and optimal dose of
streptozotocin (STZ-HFD) to yield the type 2 diabetic
rats within 4-week period.
Materials and methods
Animals and treatment
The research has been approved by
Chulalongkorn University Animal Care and Use
Committee (approved certificate no. 022/2562) and
were carried out in accordance with the guidelines
for the care and use of laboratory animals. Six-weekold male Wistar (BrlHan:Wist@Jcl) rats were
purchased from Nomura Siam International,
Co.Ltd, (n = 8, average weight 200 - 240 grams) and
acclimatized for two weeks. The rats were housed
in two per cage in an environmentally controlled room
(12 hr. light/dark cycle, 23  1C temperature) and
had free access to normal chow (Mouse Feed Food
No. 082, C.P. Company, Bangkok, Thailand) and water
all the time. Then rats were divided into two groups
(n = 4 each): control group which was continued
normal chow (20.0% energy from fat) and STZ-HFD
group which was fed with high fat diet (HFD, 58.0%
energy from fat) for 1 week before induction by
Streptozotocin. The composition of 082 chow diet and
HFD is described in Table 1.
STZ-HFD induced type 2 diabetes
High-fat diet is prepared in-house by mixing of
082 chow, lard and casein to have energy from fat
about 58.0 - 60.0%. The diet was formed and stored
in 4C refrigerator until use, but not over than 10 days.
For the STZ-HFD group, after 1-week HFD-fed, rats
were starved for 8 hours before intraperitoneal STZ
injection at week-0 of experiment. Fresh STZ solution
was prepared by dissolving in 0.1M citrate buffer and
injected at a dose of 30 mg/kg without wasting time
(~2 min). Experimental design is shown in Figure 1.

Vol. 65 No. 4
October - December 2021

Four-week induction of type 2 diabetes mellitus in rats by streptozotocin
and high-fat diet

451

Table 1. The composition of normal chow and high fat diet.
Composition
(%energy)

Normal chow diet
(c.p.082) (%)

High fat diet
(HFD) (%)

Carbohydrate
Protein
Fat

56.6
23.8
19.6

26.9
14.9
58.2

(Week - 2)

(Week - 1)

Start experiment
(Week 0)

end
(Week - 4)

Control group
c.p.082

STZ-HFD group
c.p.082

HFD

STZ
30 mg/kg

Figure 1. Experimental design.

Sample collection
The body weight and food intake of each rat
were recorded once a week. The rats were fasted
for 12 hr before blood collection. Blood samples were
collected from the tail vein each week in different
tubes for whole blood (Ethylene diamine tetraacetic
acid (EDTA) tube) and plasma (heparinized tube).
Plasma was separated by centrifugation. Urine
samples were collected in metabolic cages. In
addition, liver and kidney tissues were harvested
from a STZ-HFD rat that accidentally perished after
the end of the experiment (week 5).
Biochemical analyses
Blood sugar was measured by glucose strip test
(EasyMax, EnMax, Canada). Blood and urine
samples were sent to Laboratory Medicine, King
Chulalongkorn Memorial Hospital for enzymatic
calorimetric measurement by an automated clinical
chemistry analyzer. Insulin was measured by
Insulin (INS) ELISA Kit (Cat.No.MBS2602037,
Mybiosource Inc, San Diego, USA). Then The
homeostatic model assessment for insulin resistance
index (HOMA-IR) was calculated according to Roza
NA, et al. (9)
Histology
Liver and kidney tissues were obtained from a
rat whom unintentionally succumbed during the

anesthesia 1 week after the end of the experiment.
Liver and kidneys were fixed in 10.0% buffered
formalin and embedded in paraffin. The sections of
these tissues were stained with hematoxylin and eosin
for light microscopy to evaluate liver and kidney
pathology related to diabetes mellitus.
Statistical analysis
The results are expressed in terms of the mean 
standard deviation (SD) of the mean. A Student’s
t - test was used to evaluate the difference between
groups for independent samples. The differences
were considered significant at P < 0.05. GraphPad
Prism (GraphPad Software, USA) version 7 was used
for statistical analysis in the present study.
Results
Characteristics of STZ-HFD rats
STZ-HFD rats gained more weight than the
control rats, with significantly higher weight at
week 1 and later, although no difference in energy
intake was observed during this period. There was no
correlation between weight gain and food intake each
week (Pearson correlation r = - 0.005, P = 0.964)
These results suggested that STZ-HFD induced body
weight gain which was independent to total energy
consumption (Figure 2).
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Figure 2. (A) Morphology and size of experimental rats from each group; (B) The average body weight of each group
(P = 0.459, 0.042, 0.033, 0.017, and 0.017, respectively); (C) Food intake (P = 0.016, 0.571, 0.786, 0.786, and 0.057,
respectively). Data are shown as means  SD (n = 4). *P < 0.05 versus control group.

STZ-HFD rats developed insulin resistance
As shown in Figure 3, blood sugar, insulin and
HOMA-IR levels trended to be elevated in STZ-HFD
group since week 0. In week 3, the STZ-HFD group
had significantly higher plasma insulin and HOMAIR than the control group. We implied that STZ-HFD
protocol successfully induced type 2 DM in rats at
week 3 of the experiment. HbA1C was not statistically
different between these group because its long halflife, although STZ-HFD rats appeared to have slightly
elevated HbA1c level compared with the control.
Effects of STZ-HFD on renal and liver functions
Renal function
Urine creatinine, urine microalbumin, microalbumin / creatinine ratio and plasma creatinine
levels are shown as Figure 4. Although no statistical

significance was obtained, the STZ-HFD trended to
have a slightly elevated plasma creatinine compared
with the control group. Renal pathology of a single
STZ-HFD rat revealed a large glomerulus size that
was compatible with the early pathological change
detected in diabetic nephropathy.
Liver function
Liver histology of a single STZ-HFD rat
demonstrated fat droplets accumulated in hepatocytes
accompanied with tortuous bile canaliculi, suggested
subacute liver injury (Figure 5). This may indicate
that STZ-HFD induction induce liver injury and
fatty change in rats. However, additional number of
animals with longer period of experiment are required
for validation of these findings.
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Figure 3. (A) Fasting blood glucose (P = 0.945, 0.690, 0.229, and 0.573, respectively); (B) Fasting plasma insulin
(P = 0.150, 0.057, 0.008, and 0.268, respectively); (C) HOMA-IR index (P = 0.133, 0.107, 0.049, and 0.265,
respectively); (D) HbA1C at week 4 (P = 0.265). Data are shown as means ± SD (n = 4). *P < 0.05 versus
control group.

Discussion
Since the pathogenesis and consequences
of type 1 and type 2 DM are distinctive, all research
required a clear definition and validation for
the classification of diabetes. The most distinct
characteristic between type 1 and type 2 DM was
the level of serum insulin, which was very low in
type 1 and typically high in type 2. In general, the
Homeostasis Model Assessment of Insulin Resistance
(HOMA-IR) which is the multiplied factor between
serum glucose and insulin has been extensively used
to determine the type of DM. The low HOMA-IR
with high serum glucose indicated the insulin
deficiency, while high HOMA-IR with high
glucose represented insulin resistance. (10 - 12) However,
a universal cut-off point has not been established
because the variation between animal species.
Therefore, type 2 DM was commonly identified

as a high HOMA-IR with high blood glucose.
Regarding this, the present study also used HOMAIR to announce insulin resistance.
According to the previous literatures in both mice
and rats revealed the preferable age of rats was
between 5 - 12 weeks, average weight of 140 - 200 g,
with HFD-induction phase was from 2 - 8 weeks,
and doses of STZ injection range between 25 - 50
mg/kg, intravenously or intraperitoneally. (13, 14)
A few studies administered STZ twice during
their experiments. The results showed that using
low dose STZ (20 - 30 mg/kg i.p.) was commonly
used with a long period of HFD induction
(4 - 8 weeks). While high dose STZ (35 - 50 mg/kg
i.p.) administration, especially intravenous route,
frequently caused hypoinsulinemia in the late stage.
In addition, not all protocol could induce abnormal
plasma lipid profiles or hepatic enzymes. (15, 16)
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Figure 4. Renal function: Creatinine and albumin levels at week 4. (A) Urine creatinine (P = 0.374); (B) Urine microalbumin
(P = 0.506); (C) Microalbumin/creatinine ratio (P = 0.766, D) Plasma creatinine (P = 0.467). Data are shown as
means  SD (n = 4); (E) Kidney sections were stained with H&E and representative images (magnification: 40×)
of STZ-HFD group are shown.
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Figure 5. (A) Liver sections were stained with H&E and representative images (magnification: 40×) of STZ-HFD group
are shown; (B) Alanine aminotransferase (ALT) level (P = 0.168). Data are shown as means  SD (n = 4).

The aim of this study was to establish a protocol
to produce type 2 DM rats with reasonable budget
and uncomplicated. The induction period was likewise
considered to shorten the caring time and cost. Our
study adapted the former protocols, aimed to produce
type 2 diabetic rats with hyperinsulinemia in a short
period of experiment. Initially, we designed our inhouse HFD with targeted fat energy more than 50.0%
of total calorie, mixing with standard rat chow.
Pre-treated HFD feeding was a vital step to activate
beta cell proliferation and effective response to
low - medium dose of STZ. We decided to feed the
rats with HFD for 1 week since there was an evidence
that 1-week HFD introduction was adequate to induce
the elevation of plasma insulin. A 30 mg/kg of STZ
for intraperitoneal injection single dose was used in
our study to prevent extensive destruction of beta cell.
STZ preparation was another critical step since STZ
was easily degenerated after dissolving in citrate
buffer. We recommended the instant preparation and
injection of STZ solution within 3 minutes to minimize
the ineffectiveness of the drug.
Even though our protocol could validate the
type 2 DM disease after 3 weeks of the experiment,
the drawback of our short-induction time, low dose
STZ-HFD was that we could not obtain very high
blood sugar (> 200 mg/dL) in the first few weeks
after STZ injection as previous reports. (2, 7, 8) Insulin
measurement, which was not a routine laboratory test,
was used in our study to confirm high HOMA-IR level.
In case that the researcher does not intent to measure
serum insulin, we suggested a protocol of 2-week
HFD feeding and high dose STZ (40 mg/kg)
intraperitoneal injection, which high blood sugar (13 - 15)
could be obtained in the first 2 weeks after STZ

administration. (17 - 19) However, researchers should
take precaution of pervasive destruction of beta cell
and late stage hypoinsulinemia development.
Regarding to HFD, since the commercial HFD is
expensive (more than 1,000 baht per kilogram), we
develop an in-house HFD recipe using normal chow,
lard, and casein. Lard was a regular lipid source used
in standard HFD recipe due to the high content of
saturated fatty acid and cholesterol. Basically, HFD
contains energy from fat over than 50.0% (preferable
55.0 – 70.0%); however, our previous pilot study found
that increasing the fat content to 65.0% of energy by
lard had some disadvantages in the forming and
rancidity of the diet, as well as the perishability. In
addition, the content of protein lower than 13.0% of
total energy might relate to the failure-to-thrive and
poor weight gain of the rats. Thus, we recommend
the composition of fat about 55.0 - 65.0%, protein
13.5 - 15.0% and carbohydrate about 20.0 - 30.0%
of total energy. The HFD should be stored in 4C
refrigerator for up to 7 - 10 days.
In summary, we proposed a rat model using
STZ-HFD induction for type 2 diabetic animal study.
This technique was convenient, economical, and short
duration of induction. The downside of our model was
that the blood sugar of rats was not high at day 7 - 10
after STZ injection, which could not be used to monitor
the diabetic progression. We considered that this
was due to the limited beta cell destruction from low
dose STZ causing compensatory hyperinsulinemia
and normoglycemia. We suggested to prolong the
pre-treatment HFD period or slightly increased the
dosage of STZ to 35 - 40 mg/kg if the researcher
requires the early phase of hyperglycemia.
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Conclusion
This study demonstrates that a combination of low
dose STZ injection (30 mg/kg) with HFD feeding
(58.0% energy from fat) can induce a type 2 diabetes
mellitus in rat within 4 weeks.
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